A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients

Part of paid clinical trials in Berkeley, California.

Sponsor
Glaxo Wellcome
Study ID
NCT00005663
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to see if valacyclovir (Valtrex) is a safe and effective treatment for ano-genital HSV infections (herpes simplex virus infections of the anus and external genitals) in HIV-infected patients.

Key Dates

Start date
Jun 30, 1999
Status verified
Jul 2001

Study Design

Primary purpose
TREATMENT

Locations (20)

FacilityCityStateZIPSite coordinators
East Bay AIDS CtrBerkeleyCalifornia94705-
Pacific Oaks ResearchBeverly HillsCalifornia90211-
Kraus Med PartnersLos AngelesCalifornia90036-
ViRx IncSan FranciscoCalifornia94109-
IDC Research InitiativeAltamonte SpringsFlorida32701-
Healthnet InstituteFort LauderdaleFlorida33316-
Univ of Miami School of MedicineMiamiFlorida331361013-
Treasure Coast Infectious Disease ConsultantsVero BeachFlorida32960-
Palm Beach Research CtrWest Palm BeachFlorida33409-
Indiana Univ School of Medicine / Dept of Infect DisIndianapolisIndiana46202-
Univ of MinnesotaMinneapolisMinnesota55455-
Advanced Biomedical Research IncHackensackNew Jersey07601-
Nalle Clinic / Clinical Research DeptCharlotteNorth Carolina28207-
Wake County Dept of HealthRaleighNorth Carolina27610-
Westover Heights ClinicPortlandOregon97210-
Philadelphia FIGHTPhiladelphiaPennsylvania19107-
Dr Alvan FisherProvidenceRhode Island02907-
Baylor College of Medicine / Dept of MedicineHoustonTexas770303498-
Richmond AIDS ConsortiumRichmondVirginia23219-
Univ of Washington Virology Research ClinicSeattleWashington98122-

Find similar trials in Berkeley, CA

By condition
By specialty

Related Studies